Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer

Stephen Johnston, Mark Basik, Roberto Hegg, Wirote Lausoontornsiri, Lukasz Grzeda, Mark Clemons, Lydia Dreosti, Helen Mann, Mary Stuart, Massimo Cristofanilli

Breast Cancer Research and Treatment · 2016 · 49 citations · 23 references

Concepts

References

23